NanoPhotonica Launches Advisory Board of World-Renowned Experts
UF startup NanoPhotonica announced the launch of a world-class advisory board, building on its growing industry presence. Members of NanoPhotonica’s Advisory Board are highly regarded entrepreneurs, technologists, and c-suite executives with long-standing credibility in the materials and commercialization aspects of flat panel displays. They will support the Company at a pivotal time as it works […]
Zimmer Biomet and RTI Surgical® Partner with AAID Foundation to Expand Access to Dental Care for Veterans
Zimmer Biomet and UF startup RTI Surgical Holdings, Inc. announced they are donating a supply of dental implants and wound care products to the American Academy of Implant Dentistry Foundation (AAIDF) for an initiative benefitting veterans of the United States Armed Forces. The AAIDF is the charitable arm of the American Academy of Implant Dentistry, […]
Ology Bioservices Wins Two Department of Defense Awards Totaling More Than $135 Million
UF startup Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced that the Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded the company with two contracts valued at $135.4 million. The first is for the development of a medical countermeasure, and the […]
BSI Team Joins Forces With Oragenics in Search for New Antibiotics
A biophysics team led by Florida International University researchers Prem Chapagain and Bernard Gerstman has joined forces with UF Innovate | Sid Martin Biotech resident client Oragenics Inc. in an effort that could lead to the development of new compounds to treat life-threatening infections. Oragenics develops antibiotics that can be used against infectious diseases and […]
AGTC Announces Reaching Enrollment Milestones in Phase 1/2 Clinical Trials
UF startup Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has achieved enrollment milestones in two of its Phase 1/2 clinical trials. The company completed enrollment of the dose escalation portion of the achromatopsia (ACHM) CNGB3 trial, […]
Banyan Biomarkers, Abbott Ink Deal for Traumatic Brain Injury Biomarkers
UF startup and UF Innovate | Sid Martin Biotech alum Banyan Biomarkers announced that it has nonexclusively licensed its proprietary blood biomarkers of traumatic brain injury (TBI) to Abbott. The biomarkers — ubiquitin carboxyl-terminal hydrolase-L1 and glial fibrillary acidic protein — can be detected in blood soon after a brain injury. They are the basis […]
RTI Surgical Enrolls First Patient to Evaluate Fortilink 3D Printed Spinal Implants
RTI Surgical, a UF startup and UF Innovate | Sid Martin Biotech alum, has enrolled its first Degenerative Disc Disease (DDD) patient for clinical evaluation of its Fortilink Interbody Fusion (IBF) 3D printed implants. The Fortilink IBF devices are made using the company’s TETRAfuse 3D Technology which integrates 3D printed nano-rough surfaces for enhanced protein […]
RTI Surgical Enrolls First Patient in FORTE Clinical Study of Fortilink® Interbody Fusion Device with TETRAfuse® 3D Technology
UF startup RTI Surgical Holdings, Inc., a global surgical implant company, announced it enrolled the first patient in its Clinical Evaluation of Fortilink® Interbody Fusion Device with TETRAfuse® 3D Technology in Subjects with Degenerative Disc Disease (FORTE) study. RTI Surgical graduated from UF Innovate | Sid Martin Biotech. FORTE is a prospective, multicenter post-market evaluation of the […]
Oragenics, Inc. Announces Enrollment of 60th Patient in Clinical Trial
UF Innovate | Sid Martin Biotech resident client Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced the enrollment of the 60th patient in its Phase 2 double-blind, placebo-controlled clinical trial of AG013. AG013 is an oral mouth rinse composed of a recombinant Lactococcus lactisbacteria […]
RTI Surgical Completes Acquisition of Paradigm Spine
UF startup RTI Surgical has announced it has completed the acquisition of Paradigm Spine. Paradigm Spine’s primary product is the Coflex interlaminar stabilisation device. According to a press release, this is a “differentiated, minimally invasive motion preserving stabilisation implant that is FDA PMA-approved for the treatment of moderate to severe lumbar spinal stenosis (LSS) in […]